Systemic lupus erythematosus

Antiphospholipid antibody tests: spreading the net
M L Bertolaccini, S Gomez, J F P Pareja, A Theodoridou, G Sanna, G R V Hughes, M A Khamashta

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1639-1643; DOI: 10.1136/ard.2005.035824
RS3PE syndrome presenting as vascular endothelial growth factor associated disorder
K Arima, T Origuchi, M Tamai, N Iwanaga, Y Izumi, M Huang, F Tanaka, M Kamachi, K Aratake, H Nakamura, H Ida, M Uetani, A Kawakami, K Eguchi

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1653-1655; DOI: 10.1136/ard.2004.032995
Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement
M Bijl, E Reefman, G Horst, P C Limburg, C G M Kallenberg

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 57-63; DOI: 10.1136/ard.2005.035733
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
L Barile-Fabris, R Ariza-Andraca, L Olguín-Ortega, L J Jara, A Fraga-Mouret, J M Miranda-Limón, J Fuentes de la Mata, P Clark, F Vargas, J Alocer-Varela

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 620-625; DOI: 10.1136/ard.2004.025528
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis
B Ostendorf, C Iking-Konert, K Kurz, G Jung, O Sander, M Schneider

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 630-633; DOI: 10.1136/ard.2004.025858
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
O Flossmann, R B Jones, D R W Jayne, R A Luqmani

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 841-844; DOI: 10.1136/ard.2005.048900
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease
A Holvast, A Huckriede, J Wilschut, G Horst, J J C De Vries, C A Benne, C G M Kallenberg, M Bijl

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 913-918; DOI: 10.1136/ard.2005.043943
Repeated B cell depletion in treatment of refractory systemic lupus erythematosus
K P Ng, M J Leandro, J C Edwards, M R Ehrenstein, G Cambridge, D A Isenberg

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 942-945; DOI: 10.1136/ard.2005.044487
Prophylactic use of antibiotics and immunisations in patients with SLE
W R Gilliland, G C Tsokos

Annals of the Rheumatic Diseases Mar 2002, 61 (3) 191-192; DOI: 10.1136/ard.61.3.191
Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives
M W van der Linden, T van Lopik, L A Aarden, R G J Westendorp, T W J Huizinga

Annals of the Rheumatic Diseases Mar 2001, 60 (3) 237-241; DOI: 10.1136/ard.60.3.237

Main menu

Systemic lupus erythematosus

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic lupus erythematosus

Pages